Primidone (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Primidone" in Italian language version.

refsWebsite

Global rank Italian rank

99nih.gov

4^th place

9^th place

25archive.org

6^th place

8^th place

16doi.org

2^nd place

7^th place

11oadoi.org

799^th place

22^nd place

6web.archive.org

1^st place

2drugs.com

399^th place

1,563^rd place

1drugbank.ca

4,294^th place

low place

1torrinomedica.it

low place

2,002^nd place

1drugbank.com

low place

4,124^th place

1books.google.com

3^rd place

14^th place

1medicines.org.uk

3,823^rd place

low place

1thepigsite.com

low place

archive.org

RH. Mattson, Selection of drugs for the treatment of epilepsy, in Semin Neurol, vol. 10, n. 4, dicembre 1990, pp. 406-13, DOI:10.1055/s-2008-1063985, PMID 2287835.
AM. Kanner, J. Parra; M. Frey, The "forgotten" cross-tolerance between phenobarbital and primidone: it can prevent acute primidone-related toxicity, in Epilepsia, vol. 41, n. 10, ottobre 2000, pp. 1310-4, PMID 11051127.
A. Warner, M. Privitera; D. Bates, Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry, in Clin Chem, vol. 44, n. 5, maggio 1998, pp. 1085-95, PMID 9590393.
Ritschel, W. A., Handbook of basic pharmacokinetics-- including clinical applications, Hamilton, Ill, Drug Intelligence Publications, 1992, ISBN 0-914768-50-6.
Z. Desta, NV. Soukhova; DA. Flockhart, Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A, in Antimicrob Agents Chemother, vol. 45, n. 2, febbraio 2001, pp. 382-92, DOI:10.1128/AAC.45.2.382-392.2001, PMID 11158730.
MS. Kappy, J. Buckley, Primidone intoxication in a child, in Arch Dis Child, vol. 44, n. 234, aprile 1969, pp. 282-4, PMID 5779436.
S. Calzetti, LJ. Findley; F. Pisani; A. Richens, Phenylethylmalonamide in essential tremor. A double-blind controlled study, in J Neurol Neurosurg Psychiatry, vol. 44, n. 10, ottobre 1981, pp. 932-4, PMID 7031184.
Meir H. Kryger, Principles and practice of sleep medicine, 2000, ISBN 0-7216-7670-7. URL consultato il 3 luglio 2010.
S. LIVINGSTON, D. PETERSEN, Primidone (mysoline) in the treatment of epilepsy; results of treatment of 486 patients and review of the literature, in N Engl J Med, vol. 254, n. 7, febbraio 1956, pp. 327-9, PMID 13288784.
BH. SMITH, FL. MCNAUGHTON, Mysoline, a new anticonvulsant drug; its value in refractory cases of epilepsy, in Can Med Assoc J, vol. 68, n. 5, maggio 1953, pp. 464-7, PMID 13042720.
C. Powell, MJ. Painter; CE. Pippenger, Primidone therapy in refractory neonatal seizures, in J Pediatr, vol. 105, n. 4, ottobre 1984, pp. 651-4, PMID 6481545.
DL. DeSilvey, AJ. Moss, Primidone in the treatment of the long QT syndrome: QT shortening and ventricular arrhythmia suppression, in Ann Intern Med, vol. 93, n. 1, luglio 1980, pp. 53-4, PMID 7396315.
RR. Monroe, SP. Wise, Combined phenothiazine, chlordiazepoxide and primidone therapy for uncontrolled psychotic patients, in Am J Psychiatry, vol. 122, n. 6, dicembre 1965, pp. 694-8, PMID 5320821.
SG. Hayes, Barbiturate anticonvulsants in refractory affective disorders, in Ann Clin Psychiatry, vol. 5, n. 1, marzo 1993, pp. 35-44, PMID 8348197.
AJ. Gelenberg, JW. Jefferson, Lithium tremor, in J Clin Psychiatry, vol. 56, n. 7, luglio 1995, pp. 283-7, PMID 7615481.
RD. Bruun, Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder, in Am J Psychiatry, vol. 145, n. 5, maggio 1988, pp. 621-4, PMID 2895987.
GB. Fogazzi, Crystalluria: a neglected aspect of urinary sediment analysis, in Nephrol Dial Transplant, vol. 11, n. 2, febbraio 1996, pp. 379-87, PMID 8671802.
MG. Hart, G. Hooper, Clinical associations of Dupuytren's disease, in Postgrad Med J, vol. 81, n. 957, luglio 2005, pp. 425-8, DOI:10.1136/pgmj.2004.027425, PMID 15998816.
EM. Critchley, SD. Vakil; HW. Hayward; VM. Owen, Dupuytren's disease in epilepsy: result of prolonged administration of anticonvulsants, in J Neurol Neurosurg Psychiatry, vol. 39, n. 5, maggio 1976, pp. 498-503, PMID 932769.
M. Schwaninger, P. Ringleb; R. Winter; B. Kohl; W. Fiehn; PA. Rieser; I. Walter-Sack, Elevated plasma concentrations of homocysteine in antiepileptic drug treatment, in Epilepsia, vol. 40, n. 3, marzo 1999, pp. 345-50, PMID 10080517.
NC. Reynolds, RM. Miska, Safety of anticonvulsants in hepatic porphyrias, in Neurology, vol. 31, n. 4, aprile 1981, pp. 480-4, PMID 7194443.
H. Arif, R. Buchsbaum; D. Weintraub; S. Koyfman; C. Salas-Humara; CW. Bazil; SR. Resor; LJ. Hirsch, Comparison and predictors of rash associated with 15 antiepileptic drugs, in Neurology, vol. 68, n. 20, maggio 2007, pp. 1701-9, DOI:10.1212/01.wnl.0000261917.83337.db, PMID 17502552.
EH. Reynolds, JF. Hallpike; BM. Phillips; DM. Matthews, Reversible absorptive defects in anticonvulsant megaloblastic anaemia, in J Clin Pathol, vol. 18, n. 5, settembre 1965, pp. 593-8, PMID 5835440.
MD. O'Brien, SK. Gilmour-White, Management of epilepsy in women, in Postgrad Med J, vol. 81, n. 955, maggio 2005, pp. 278-85, DOI:10.1136/pgmj.2004.030221, PMID 15879038.
G. Stores, Behavioural effects of anti-epileptic drugs, in Dev Med Child Neurol, vol. 17, n. 5, ottobre 1975, pp. 647-58, PMID 241674.

books.google.com

Gian Maria Pacifici, Interindividual Variability in Human Drug Metabolism, Taylor & Francis, 2001, ISBN 978-0-7484-0864-1.

doi.org

dx.doi.org

TA. Zesiewicz, R. Elble; ED. Louis; RA. Hauser; KL. Sullivan; RB. Dewey; WG. Ondo; GS. Gronseth; WJ. Weiner, Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology, in Neurology, vol. 64, n. 12, giugno 2005, pp. 2008-20, DOI:10.1212/01.WNL.0000163769.28552.CD, PMID 15972843.
RH. Mattson, Selection of drugs for the treatment of epilepsy, in Semin Neurol, vol. 10, n. 4, dicembre 1990, pp. 406-13, DOI:10.1055/s-2008-1063985, PMID 2287835.
Z. Desta, NV. Soukhova; DA. Flockhart, Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A, in Antimicrob Agents Chemother, vol. 45, n. 2, febbraio 2001, pp. 382-92, DOI:10.1128/AAC.45.2.382-392.2001, PMID 11158730.
P. Imming, C. Sinning; A. Meyer, Drugs, their targets and the nature and number of drug targets, in Nat Rev Drug Discov, vol. 5, n. 10, ottobre 2006, pp. 821-34, DOI:10.1038/nrd2132, PMID 17016423.
JP. Overington, B. Al-Lazikani; AL. Hopkins, How many drug targets are there?, in Nat Rev Drug Discov, vol. 5, n. 12, dicembre 2006, pp. 993-6, DOI:10.1038/nrd2199, PMID 17139284.
Gallagher BB, Smith DB, Mattson RH, The relationship of the anticonvulsant properties of primidone to phenobarbital, in Epilepsia, vol. 11, n. 3, settembre 1970, pp. 293–301, DOI:10.1111/j.1528-1157.1970.tb03893.x, PMID 5276420.
D. Christidis, D. Kalogerakis; TY. Chan; D. Mauri; G. Alexiou; A. Terzoudi, Is primidone the drug of choice for epileptic patients with QT-prolongation? A comprehensive analysis of literature, in Seizure, vol. 15, n. 1, gennaio 2006, pp. 64-6, DOI:10.1016/j.seizure.2005.10.002, PMID 16309926.
C. Barrios, TA. Chaudhry; PJ. Goodnick, Rapid cycling bipolar disorder, in Expert Opin Pharmacother, vol. 2, n. 12, dicembre 2001, pp. 1963-73, DOI:10.1517/14656566.2.12.1963, PMID 11825328.
B. Arbaizar, I. Gómez-Acebo; J. Llorca, Postural induced-tremor in psychiatry, in Psychiatry Clin Neurosci, vol. 62, n. 6, dicembre 2008, pp. 638-45, DOI:10.1111/j.1440-1819.2008.01877.x, PMID 19067999.
MG. Hart, G. Hooper, Clinical associations of Dupuytren's disease, in Postgrad Med J, vol. 81, n. 957, luglio 2005, pp. 425-8, DOI:10.1136/pgmj.2004.027425, PMID 15998816.
H. Arif, R. Buchsbaum; D. Weintraub; S. Koyfman; C. Salas-Humara; CW. Bazil; SR. Resor; LJ. Hirsch, Comparison and predictors of rash associated with 15 antiepileptic drugs, in Neurology, vol. 68, n. 20, maggio 2007, pp. 1701-9, DOI:10.1212/01.wnl.0000261917.83337.db, PMID 17502552.
HA. Valsamis, SK. Arora; B. Labban; SI. McFarlane, Antiepileptic drugs and bone metabolism, in Nutr Metab (Lond), vol. 3, 2006, p. 36, DOI:10.1186/1743-7075-3-36, PMID 16956398.
MD. O'Brien, SK. Gilmour-White, Management of epilepsy in women, in Postgrad Med J, vol. 81, n. 955, maggio 2005, pp. 278-85, DOI:10.1136/pgmj.2004.030221, PMID 15879038.
M. Lopez-Gomez, J. Ramirez-Bermudez; C. Campillo; AL. Sosa; M. Espinola; I. Ruiz, Primidone is associated with interictal depression in patients with epilepsy, in Epilepsy Behav, vol. 6, n. 3, maggio 2005, pp. 413-6, DOI:10.1016/j.yebeh.2005.01.016, PMID 15820351.
H. Katano, T. Fukushima; K. Karasawa; N. Sugiyama; A. Ohkura; K. Kamiya, Primidone-induced hyperammonemic encephalopathy in a patient with cerebral astrocytoma, in J Clin Neurosci, vol. 9, n. 1, gennaio 2002, pp. 79-81, DOI:10.1054/jocn.2001.1011, PMID 11749025.
CL. Harden, PB. Pennell; BS. Koppel; CA. Hovinga; B. Gidal; KJ. Meador; J. Hopp; TY. Ting; WA. Hauser; D. Thurman; PW. Kaplan, Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society, in Neurology, vol. 73, n. 2, luglio 2009, pp. 142-9, DOI:10.1212/WNL.0b013e3181a6b325, PMID 19398680.

drugbank.ca

DrugBank: Showing Primidone (DB00794), su drugbank.ca. URL consultato il 12 luglio 2010.

drugbank.com

go.drugbank.com

(EN) Primidone, su go.drugbank.com. URL consultato il 1º novembre 2023.

drugs.com

medicines.org.uk

emc.medicines.org.uk

Mysoline 250 mg Tablets ^{[collegamento interrotto]}, su emc.medicines.org.uk. URL consultato il 3 luglio 2010.

nih.gov

ncbi.nlm.nih.gov

K. Murphy, N. Delanty, Primary Generalized Epilepsies, in Curr Treat Options Neurol, vol. 2, n. 6, novembre 2000, pp. 527-542, PMID 11096777.
TA. Zesiewicz, R. Elble; ED. Louis; RA. Hauser; KL. Sullivan; RB. Dewey; WG. Ondo; GS. Gronseth; WJ. Weiner, Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology, in Neurology, vol. 64, n. 12, giugno 2005, pp. 2008-20, DOI:10.1212/01.WNL.0000163769.28552.CD, PMID 15972843.
Monroe RR, Wise SP 3rd. Combined phenothiazine, chlordiazepoxide and primidone therapy for uncontrolled psychotic patients. Am J Psychiatry. 1965 Dec;122(6):694-8. PMID 5320821.
Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia.1995;36 Suppl 2:S2-12. Review. PMID 8784210
Discussion on recent advances in treatment, in Proc R Soc Med, vol. 49, n. 8, agosto 1956, pp. 583-94, PMID 13359420.
D. Morley, NA. Wynne, Acute primidone poisoning in a child, in Br Med J, vol. 1, n. 5010, gennaio 1957, p. 90, PMID 13383203.
G. Dotevall, B. Herner, Treatment of acute primidone poisoning with bemegride and amiphenazole, in Br Med J, vol. 2, n. 5042, agosto 1957, pp. 451-2, PMID 13446511.
IG. Fazekas, B. Rengei, Fatal poisoning (suicide) with mysoline and phenobarbital, in Arch Toxikol, vol. 18, 1960, pp. 213-33, PMID 13698457.
AN. van Heijst, W. de Jong; R. Seldenrijk; A. van Dijk, Coma and crystalluria: a massive primidone intoxication treated with haemoperfusion, in J Toxicol Clin Toxicol, vol. 20, n. 4, giugno 1983, pp. 307-18, PMID 6655772.
PJ. Loiseau, Clinical experience with new antiepileptic drugs: antiepileptic drugs in Europe, in Epilepsia, 40 Suppl 6, 1999, pp. S3-8; discussion S73-4, PMID 10530675.
MJ. Newman, DW. Sumner, Megaloblastic anemia following the use of primidone, in Blood, vol. 12, n. 2, febbraio 1957, pp. 183-8, PMID 13403983.
H. Fuld, EH. Moorhouse, Observations on megaloblastic anaemias after primidone, in Br Med J, vol. 1, n. 4974, maggio 1956, pp. 1021-3, PMID 13304415.
SR. Meadow, Congenital abnormalities and anticonvulsant drugs., in Proc R Soc Med, vol. 63, n. 1, gennaio 1970, pp. 48-9, PMID 5417773.
IC. Roman, A. Caratzali, Effects of anticonvulsant drugs on chromosomes, in Br Med J, vol. 4, n. 5781, ottobre 1971, p. 234, PMID 5115838.
RJ. Schain, Pediatrics-Epitomes of Progress: Carbamazepine (Tegretol) in the Treatment of Epilepsy, in West J Med, vol. 128, n. 3, marzo 1978, pp. 231-232, PMID 18748164.
EA. Rodin, CS. Rim; H. Kitano; R. Lewis; PM. Rennick, A comparison of the effectiveness of primidone versus carbamazepine in epileptic outpatients, in J Nerv Ment Dis, vol. 163, n. 1, luglio 1976, pp. 41-6, PMID 819630.
RH. Mattson, Selection of drugs for the treatment of epilepsy, in Semin Neurol, vol. 10, n. 4, dicembre 1990, pp. 406-13, DOI:10.1055/s-2008-1063985, PMID 2287835.
KD. Laxer, Guidelines for treating epilepsy in the age of felbamate, vigabatrin, lamotrigine, and gabapentin, in West J Med, vol. 161, n. 3, settembre 1994, pp. 309-14, PMID 7975572.
AM. Kanner, J. Parra; M. Frey, The "forgotten" cross-tolerance between phenobarbital and primidone: it can prevent acute primidone-related toxicity, in Epilepsia, vol. 41, n. 10, ottobre 2000, pp. 1310-4, PMID 11051127.
GJ. de Haan, JA. Carpay; CA. van Donselaar, Antiepileptic primidone shortly to be withdrawn from sale: change medication now, in Ned Tijdschr Geneeskd, vol. 147, n. 47, novembre 2003, pp. 2325-6, PMID 14669538.
A. Warner, M. Privitera; D. Bates, Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry, in Clin Chem, vol. 44, n. 5, maggio 1998, pp. 1085-95, PMID 9590393.
WD. Hooper, AM. Treston; NW. Jacobsen; RG. Dickinson; MJ. Eadie, Identification of p-hydroxyprimidone as a minor metabolite of primidone in rat and man, in Drug Metab Dispos, vol. 11, n. 6, pp. 607-10, PMID 6140148.
Z. Desta, NV. Soukhova; DA. Flockhart, Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A, in Antimicrob Agents Chemother, vol. 45, n. 2, febbraio 2001, pp. 382-92, DOI:10.1128/AAC.45.2.382-392.2001, PMID 11158730.
K. Kojima, K. Nagata; T. Matsubara; Y. Yamazoe, Broad but distinct role of pregnane x receptor on the expression of individual cytochrome p450s in human hepatocytes, in Drug Metab Pharmacokinet, vol. 22, n. 4, agosto 2007, pp. 276-86, PMID 17827782.
D. Battino, G. Avanzini; L. Bossi; D. Croci; C. Cusi; C. Gomeni; A. Moise, Plasma levels of primidone and its metabolite phenobarbital: effect of age and associated therapy, in Ther Drug Monit, vol. 5, n. 1, 1983, pp. 73-9, PMID 6845402.
MS. Kappy, J. Buckley, Primidone intoxication in a child, in Arch Dis Child, vol. 44, n. 234, aprile 1969, pp. 282-4, PMID 5779436.
RL. Macdonald, KM. Kelly, Antiepileptic drug mechanisms of action, in Epilepsia, 36 Suppl 2, 1995, pp. S2-12, PMID 8784210.
P. Imming, C. Sinning; A. Meyer, Drugs, their targets and the nature and number of drug targets, in Nat Rev Drug Discov, vol. 5, n. 10, ottobre 2006, pp. 821-34, DOI:10.1038/nrd2132, PMID 17016423.
JP. Overington, B. Al-Lazikani; AL. Hopkins, How many drug targets are there?, in Nat Rev Drug Discov, vol. 5, n. 12, dicembre 2006, pp. 993-6, DOI:10.1038/nrd2199, PMID 17139284.
S. Calzetti, LJ. Findley; F. Pisani; A. Richens, Phenylethylmalonamide in essential tremor. A double-blind controlled study, in J Neurol Neurosurg Psychiatry, vol. 44, n. 10, ottobre 1981, pp. 932-4, PMID 7031184.
S. LIVINGSTON, D. PETERSEN, Primidone (mysoline) in the treatment of epilepsy; results of treatment of 486 patients and review of the literature, in N Engl J Med, vol. 254, n. 7, febbraio 1956, pp. 327-9, PMID 13288784.
BH. SMITH, FL. MCNAUGHTON, Mysoline, a new anticonvulsant drug; its value in refractory cases of epilepsy, in Can Med Assoc J, vol. 68, n. 5, maggio 1953, pp. 464-7, PMID 13042720.
C. Powell, MJ. Painter; CE. Pippenger, Primidone therapy in refractory neonatal seizures, in J Pediatr, vol. 105, n. 4, ottobre 1984, pp. 651-4, PMID 6481545.
K. Kagitani-Shimono, K. Imai; N. Okamoto; J. Ono; S. Okada, Unverricht-Lundborg disease with cystatin B gene abnormalities, in Pediatr Neurol, vol. 26, n. 1, gennaio 2002, pp. 55-60, PMID 11814737.
RH. Mattson, JA. Cramer; JF. Collins; DB. Smith; AV. Delgado-Escueta; TR. Browne; PD. Williamson; DM. Treiman; JO. McNamara; CB. McCutchen, Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures, in N Engl J Med, vol. 313, n. 3, luglio 1985, pp. 145-51, PMID 3925335.
G. Hermanns, S. Noachtar; I. Tuxhorn; H. Holthausen; A. Ebner; P. Wolf, Systematic testing of medical intractability for carbamazepine, phenytoin, and phenobarbital or primidone in monotherapy for patients considered for epilepsy surgery, in Epilepsia, vol. 37, n. 7, luglio 1996, pp. 675-9, PMID 8681900.
DB. Smith, RH. Mattson; JA. Cramer; JF. Collins; RA. Novelly; B. Craft, Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone, in Epilepsia, 28 Suppl 3, 1987, pp. S50-8, PMID 3319543.
CM. Gruber, JT. Brock; M. Dyken, Comparison of the effectiveness of phenobarital, mephobarbital, primidone, diphenylhydantoin, ethotoin, metharbital, and methylphenylethylhydantoin in motor seizures, in Clin Pharmacol Ther, vol. 3, pp. 23-8, PMID 13902356.
PT. White, D. Plott; J. Norton, Relative anticonvulsant potency of primidone; a double blind comparison, in Arch Neurol, vol. 14, n. 1, gennaio 1966, pp. 31-5, PMID 5320823.
Gallagher BB, Smith DB, Mattson RH, The relationship of the anticonvulsant properties of primidone to phenobarbital, in Epilepsia, vol. 11, n. 3, settembre 1970, pp. 293–301, DOI:10.1111/j.1528-1157.1970.tb03893.x, PMID 5276420.
RH. Mattson, Efficacy and adverse effects of established and new antiepileptic drugs, in Epilepsia, 36 Suppl 2, 1995, pp. S13-26, PMID 8784211.
D. Battino, M. Estienne; G. Avanzini, Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide, in Clin Pharmacokinet, vol. 29, n. 4, ottobre 1995, pp. 257-86, PMID 8549027.
E. Dietrichs, V. Kvikstad, Essential tremor, in Tidsskr Nor Laegeforen, vol. 128, n. 19, ottobre 2008, pp. 2210-3, PMID 18846147.
WC. Koller, VL. Royse, Efficacy of primidone in essential tremor, in Neurology, vol. 36, n. 1, gennaio 1986, pp. 121-4, PMID 3941767.
E. Sasso, E. Perucca; R. Fava; S. Calzetti, Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis, in Clin Neuropharmacol, vol. 13, n. 1, febbraio 1990, pp. 67-76, PMID 2306749.
M. Serrano-Dueñas, Use of primidone in low doses (250 mg/day) versus high doses (750 mg/day) in the management of essential tremor. Double-blind comparative study with one-year follow-up, in Parkinsonism Relat Disord, vol. 10, n. 1, ottobre 2003, pp. 29-33, PMID 14499204.
E. Spina, G. Perugi, Antiepileptic drugs: indications other than epilepsy, in Epileptic Disord, vol. 6, n. 2, giugno 2004, pp. 57-75, PMID 15246950.
KB. Bhattacharyya, S. Basu; AD. Roy; S. Bhattacharya, Orthostatic tremor: report of a case and review of the literature, in Neurol India, vol. 51, n. 1, marzo 2003, pp. 91-3, PMID 12865532.
DP. Derleth, Treatment of apnea of prematurity, in Arch Pediatr Adolesc Med, vol. 148, n. 9, settembre 1994, p. 991, PMID 8075750.
E. Ozbag, The use of primidone in neonates with theophylline-resistant apnea, in Arch Pediatr Adolesc Med, vol. 148, n. 3, marzo 1994, pp. 332-3, PMID 8130876.
CA. Miller, M. Gaylord; V. Lorch; AW. Zimmerman, The use of primidone in neonates with theophylline-resistant apnea, in Am J Dis Child, vol. 147, n. 2, febbraio 1993, pp. 183-6, PMID 8427242.
DL. DeSilvey, AJ. Moss, Primidone in the treatment of the long QT syndrome: QT shortening and ventricular arrhythmia suppression, in Ann Intern Med, vol. 93, n. 1, luglio 1980, pp. 53-4, PMID 7396315.
YW. Lan, Primidone in the treatment of long Q-T syndrome. Clinical analysis of 4 cases, in Zhonghua Xin Xue Guan Bing Za Zhi, vol. 14, n. 6, dicembre 1986, pp. 330-2, 380, PMID 3582153.
K. Loukeris, D. Mauri; P. Pazarlis, QT length and heart function in primidone hypocalcaemia, in Acta Cardiol, vol. 57, n. 5, ottobre 2002, pp. 367-9, PMID 12405576.
D. Christidis, D. Kalogerakis; TY. Chan; D. Mauri; G. Alexiou; A. Terzoudi, Is primidone the drug of choice for epileptic patients with QT-prolongation? A comprehensive analysis of literature, in Seizure, vol. 15, n. 1, gennaio 2006, pp. 64-6, DOI:10.1016/j.seizure.2005.10.002, PMID 16309926.
KP. Letsas, M. Efremidis; LK. Pappas; G. Gavrielatos; A. Sideris; C. Charitos, Pathophysiology and management of syncope in Kearns-Sayre syndrome, in Am Heart Hosp J, vol. 4, n. 4, 2006, pp. 301-2, PMID 17086014.
RR. Monroe, SP. Wise, Combined phenothiazine, chlordiazepoxide and primidone therapy for uncontrolled psychotic patients, in Am J Psychiatry, vol. 122, n. 6, dicembre 1965, pp. 694-8, PMID 5320821.
RR. Monroe, Anticonvulsants in the treatment of aggression, in J Nerv Ment Dis, vol. 160, n. 2-1, febbraio 1975, pp. 119-26, PMID 1117287.
SG. Hayes, Barbiturate anticonvulsants in refractory affective disorders, in Ann Clin Psychiatry, vol. 5, n. 1, marzo 1993, pp. 35-44, PMID 8348197.
GM. Brown, GH. Stone; MP. Rathbone, Primidone and rapid cycling affective disorders, in Lancet, vol. 342, n. 8876, ottobre 1993, p. 925, PMID 8105181.
LC. Schaffer, CB. Schaffer; J. Caretto, The use of primidone in the treatment of refractory bipolar disorder, in Ann Clin Psychiatry, vol. 11, n. 2, giugno 1999, pp. 61-6, PMID 10440522.
C. Barrios, TA. Chaudhry; PJ. Goodnick, Rapid cycling bipolar disorder, in Expert Opin Pharmacother, vol. 2, n. 12, dicembre 2001, pp. 1963-73, DOI:10.1517/14656566.2.12.1963, PMID 11825328.
B. Arbaizar, I. Gómez-Acebo; J. Llorca, Postural induced-tremor in psychiatry, in Psychiatry Clin Neurosci, vol. 62, n. 6, dicembre 2008, pp. 638-45, DOI:10.1111/j.1440-1819.2008.01877.x, PMID 19067999.
AJ. Gelenberg, JW. Jefferson, Lithium tremor, in J Clin Psychiatry, vol. 56, n. 7, luglio 1995, pp. 283-7, PMID 7615481.
RD. Bruun, Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder, in Am J Psychiatry, vol. 145, n. 5, maggio 1988, pp. 621-4, PMID 2895987.
G. Stüttgen, Toxic epidermal necrolysis provoked by barbiturates, in Br J Dermatol, vol. 88, n. 3, marzo 1973, pp. 291-3, PMID 4541299.
J. Lorber, Primidone treatment of athetosis in children, in Br Med J, vol. 2, n. 5090, luglio 1958, p. 208, PMID 13560827.
I. Thorn, Primidone and chlordiazepoxide in cerebral palsy, in Dev Med Child Neurol, vol. 4, giugno 1962, pp. 325-7, PMID 13921015.
Sullivan FM, McElhatton PR, A comparison of the teratogenic activity of the antiepileptic drugs carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin, and primidone in mice, in Toxicol Appl Pharmacol, 1977, PMID 877966.
Reynolds NC Jr, Miska RM, Safety of anticonvulsants in hepatic porphyrias, in Int Rev Neurobiol, 2008, PMID 7194443.
GB. Fogazzi, Crystalluria: a neglected aspect of urinary sediment analysis, in Nephrol Dial Transplant, vol. 11, n. 2, febbraio 1996, pp. 379-87, PMID 8671802.
MG. Hart, G. Hooper, Clinical associations of Dupuytren's disease, in Postgrad Med J, vol. 81, n. 957, luglio 2005, pp. 425-8, DOI:10.1136/pgmj.2004.027425, PMID 15998816.
EM. Critchley, SD. Vakil; HW. Hayward; VM. Owen, Dupuytren's disease in epilepsy: result of prolonged administration of anticonvulsants, in J Neurol Neurosurg Psychiatry, vol. 39, n. 5, maggio 1976, pp. 498-503, PMID 932769.
M. Schwaninger, P. Ringleb; R. Winter; B. Kohl; W. Fiehn; PA. Rieser; I. Walter-Sack, Elevated plasma concentrations of homocysteine in antiepileptic drug treatment, in Epilepsia, vol. 40, n. 3, marzo 1999, pp. 345-50, PMID 10080517.
Apeland T, Mansoor MA, Strandjord RE, Kristensen O, Homocysteine concentrations and methionine loading in patients on antiepileptic drugs, in Acta Neurol. Scand., vol. 101, n. 4, aprile 2000, pp. 217–23, PMID 10770516.
NC. Reynolds, RM. Miska, Safety of anticonvulsants in hepatic porphyrias, in Neurology, vol. 31, n. 4, aprile 1981, pp. 480-4, PMID 7194443.
H. Arif, R. Buchsbaum; D. Weintraub; S. Koyfman; C. Salas-Humara; CW. Bazil; SR. Resor; LJ. Hirsch, Comparison and predictors of rash associated with 15 antiepileptic drugs, in Neurology, vol. 68, n. 20, maggio 2007, pp. 1701-9, DOI:10.1212/01.wnl.0000261917.83337.db, PMID 17502552.
MG. Harrington, HM. Hodkinson, Anticonvulsant drugs and bone disease in the elderly, in J R Soc Med, vol. 80, n. 7, luglio 1987, pp. 425-7, PMID 3656313.
HA. Valsamis, SK. Arora; B. Labban; SI. McFarlane, Antiepileptic drugs and bone metabolism, in Nutr Metab (Lond), vol. 3, 2006, p. 36, DOI:10.1186/1743-7075-3-36, PMID 16956398.
AM. Pack, MJ. Morrell, Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications, in CNS Drugs, vol. 15, n. 8, 2001, pp. 633-42, PMID 11524035.
EH. Reynolds, JF. Hallpike; BM. Phillips; DM. Matthews, Reversible absorptive defects in anticonvulsant megaloblastic anaemia, in J Clin Pathol, vol. 18, n. 5, settembre 1965, pp. 593-8, PMID 5835440.
RH. Girdwood, Drug-induced anaemias, in Drugs, vol. 11, n. 5, 1976, pp. 394-404, PMID 782836.
MD. O'Brien, SK. Gilmour-White, Management of epilepsy in women, in Postgrad Med J, vol. 81, n. 955, maggio 2005, pp. 278-85, DOI:10.1136/pgmj.2004.030221, PMID 15879038.
S. Hernández-Díaz, MM. Werler; AM. Walker; AA. Mitchell, Folic acid antagonists during pregnancy and the risk of birth defects, in N Engl J Med, vol. 343, n. 22, novembre 2000, pp. 1608-14, PMID 11096168.
Y. Biale, H. Lewenthal, Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs, in Eur J Obstet Gynecol Reprod Biol, vol. 18, n. 4, novembre 1984, pp. 211-6, PMID 6519344.
MK. Bruno, CL. Harden, Epilepsy in Pregnant Women, in Curr Treat Options Neurol, vol. 4, n. 1, gennaio 2002, pp. 31-40, PMID 11734102.
M. Lopez-Gomez, J. Ramirez-Bermudez; C. Campillo; AL. Sosa; M. Espinola; I. Ruiz, Primidone is associated with interictal depression in patients with epilepsy, in Epilepsy Behav, vol. 6, n. 3, maggio 2005, pp. 413-6, DOI:10.1016/j.yebeh.2005.01.016, PMID 15820351.
G. Stores, Behavioural effects of anti-epileptic drugs, in Dev Med Child Neurol, vol. 17, n. 5, ottobre 1975, pp. 647-58, PMID 241674.
JL. Herranz, JA. Armijo; R. Arteaga, Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children, in Epilepsia, vol. 29, n. 6, pp. 794-804, PMID 3142761.
A. Sher, JM. Andersen; SC. Bhatia, Primidone-induced catatonic schizophrenia, in Drug Intell Clin Pharm, vol. 17, n. 7-8, pp. 551-2, PMID 6872851.
RG. Schlienger, NH. Shear, Antiepileptic drug hypersensitivity syndrome, in Epilepsia, 39 Suppl 7, 1998, pp. S3-7, PMID 9798755.
H. Katano, T. Fukushima; K. Karasawa; N. Sugiyama; A. Ohkura; K. Kamiya, Primidone-induced hyperammonemic encephalopathy in a patient with cerebral astrocytoma, in J Clin Neurosci, vol. 9, n. 1, gennaio 2002, pp. 79-81, DOI:10.1054/jocn.2001.1011, PMID 11749025.
AO. Langlands, N. Maclean; JG. Pearson; ER. Williamson, Lymphadenopathy and megaloblastic anaemia in patient receiving primidone, in Br Med J, vol. 1, n. 5534, gennaio 1967, pp. 215-7, PMID 4959849.
N. Ratnaraj, VD. Goldberg; M. Hjelm, Temperature effects on the estimation of free levels of phenytoin carbamazepine and phenobarbitone, in Ther Drug Monit, vol. 12, n. 5, settembre 1990, pp. 465-72, PMID 2293409.
MS. Yerby, PN. Friel; K. McCormick, Antiepileptic drug disposition during pregnancy, in Neurology, vol. 42, 4 Suppl 5, aprile 1992, pp. 12-6, PMID 1574166.
O'Brien MD, Gilmour-White S, Epilepsy and pregnancy, in BMJ, vol. 307, n. 6902, agosto 1993, pp. 492–5, PMC 1678789, PMID 8400940.
Hovinga CA, Pennell PB, Antiepileptic drug therapy in pregnancy II: fetal and neonatal exposure, in Int Rev Neurobiol, 2008, PMID 18929086.
CL. Harden, PB. Pennell; BS. Koppel; CA. Hovinga; B. Gidal; KJ. Meador; J. Hopp; TY. Ting; WA. Hauser; D. Thurman; PW. Kaplan, Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society, in Epilepsia, vol. 50, n. 5, maggio 2009, pp. 1247-55, PMID 19507305.
CL. Harden, PB. Pennell; BS. Koppel; CA. Hovinga; B. Gidal; KJ. Meador; J. Hopp; TY. Ting; WA. Hauser; D. Thurman; PW. Kaplan, Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society, in Neurology, vol. 73, n. 2, luglio 2009, pp. 142-9, DOI:10.1212/WNL.0b013e3181a6b325, PMID 19398680.

oadoi.org

TA. Zesiewicz, R. Elble; ED. Louis; RA. Hauser; KL. Sullivan; RB. Dewey; WG. Ondo; GS. Gronseth; WJ. Weiner, Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology, in Neurology, vol. 64, n. 12, giugno 2005, pp. 2008-20, DOI:10.1212/01.WNL.0000163769.28552.CD, PMID 15972843.
P. Imming, C. Sinning; A. Meyer, Drugs, their targets and the nature and number of drug targets, in Nat Rev Drug Discov, vol. 5, n. 10, ottobre 2006, pp. 821-34, DOI:10.1038/nrd2132, PMID 17016423.
JP. Overington, B. Al-Lazikani; AL. Hopkins, How many drug targets are there?, in Nat Rev Drug Discov, vol. 5, n. 12, dicembre 2006, pp. 993-6, DOI:10.1038/nrd2199, PMID 17139284.
Gallagher BB, Smith DB, Mattson RH, The relationship of the anticonvulsant properties of primidone to phenobarbital, in Epilepsia, vol. 11, n. 3, settembre 1970, pp. 293–301, DOI:10.1111/j.1528-1157.1970.tb03893.x, PMID 5276420.
D. Christidis, D. Kalogerakis; TY. Chan; D. Mauri; G. Alexiou; A. Terzoudi, Is primidone the drug of choice for epileptic patients with QT-prolongation? A comprehensive analysis of literature, in Seizure, vol. 15, n. 1, gennaio 2006, pp. 64-6, DOI:10.1016/j.seizure.2005.10.002, PMID 16309926.
C. Barrios, TA. Chaudhry; PJ. Goodnick, Rapid cycling bipolar disorder, in Expert Opin Pharmacother, vol. 2, n. 12, dicembre 2001, pp. 1963-73, DOI:10.1517/14656566.2.12.1963, PMID 11825328.
B. Arbaizar, I. Gómez-Acebo; J. Llorca, Postural induced-tremor in psychiatry, in Psychiatry Clin Neurosci, vol. 62, n. 6, dicembre 2008, pp. 638-45, DOI:10.1111/j.1440-1819.2008.01877.x, PMID 19067999.
HA. Valsamis, SK. Arora; B. Labban; SI. McFarlane, Antiepileptic drugs and bone metabolism, in Nutr Metab (Lond), vol. 3, 2006, p. 36, DOI:10.1186/1743-7075-3-36, PMID 16956398.
M. Lopez-Gomez, J. Ramirez-Bermudez; C. Campillo; AL. Sosa; M. Espinola; I. Ruiz, Primidone is associated with interictal depression in patients with epilepsy, in Epilepsy Behav, vol. 6, n. 3, maggio 2005, pp. 413-6, DOI:10.1016/j.yebeh.2005.01.016, PMID 15820351.
H. Katano, T. Fukushima; K. Karasawa; N. Sugiyama; A. Ohkura; K. Kamiya, Primidone-induced hyperammonemic encephalopathy in a patient with cerebral astrocytoma, in J Clin Neurosci, vol. 9, n. 1, gennaio 2002, pp. 79-81, DOI:10.1054/jocn.2001.1011, PMID 11749025.
CL. Harden, PB. Pennell; BS. Koppel; CA. Hovinga; B. Gidal; KJ. Meador; J. Hopp; TY. Ting; WA. Hauser; D. Thurman; PW. Kaplan, Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society, in Neurology, vol. 73, n. 2, luglio 2009, pp. 142-9, DOI:10.1212/WNL.0b013e3181a6b325, PMID 19398680.

thepigsite.com

Primidone per uso veterinario ^{[collegamento interrotto]}, su thepigsite.com. URL consultato il 3 luglio 2010.

torrinomedica.it

Mysoline, su torrinomedica.it, Torrinomedica. URL consultato il 15 maggio 2012.

web.archive.org

Introduction to Mysoline, su epilepsy.com. URL consultato il 12 luglio 2010 (archiviato dall'url originale il 6 ottobre 2008).
Mysoline-history, su wyeth.com. URL consultato il 3 luglio 2010 (archiviato dall'url originale il 7 gennaio 2009).
Mysoline (Primidone) Drug Information: Uses, Side Effects, Drug Interactions and Warnings at RxList, su rxlist.com. URL consultato il 12 luglio 2010 (archiviato dall'url originale l'11 ottobre 2007).
(EN) Acorus Therapeutics, Ltd., Mysoline 250 mg Tablets, su electronic Medicines Compendium, Datapharm Communications and the Association of the British Pharmaceutical Industry (ABPI), 2005. URL consultato il 3 luglio 2010 (archiviato dall'url originale il 16 marzo 2008).
(EN) Broadley, Marissa A, Juvenile Myoclonic Epilepsy of Janz (JME), su The Childhood Seizure e-Book. Valhalla, New York, 2000. URL consultato il 15 maggio 2012 (archiviato dall'url originale il 9 febbraio 2012).
Mysoline per uso veterinario, su canine-epilepsy.com. URL consultato il 15 maggio 2012 (archiviato dall'url originale il 20 aprile 2012).